OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
May 16, 2018
Cambrex Corporation has announced facility, equipment, and instrument upgrades at its High Point, NC facility and updated progress on expansions in Cedar City, IA.
Valerius Biopharma will use Catalent’s GPEx technology to produce cell lines for biosimilar drugs.
May 07, 2018
Lonza announces addition of mid-scale biologics manufacturing capacity and cell-therapy suites at Portsmouth, NH site.
May 03, 2018
The company has begun expansion efforts for its process-development capabilities and laboratory infrastructure.
May 02, 2018
Bioprocess understanding, the right equipment, and automation help, but multifunctional teamwork is the key to API production success.
CDMOs can claim credit for the robust growth of emerging bio/pharma financings.
April 25, 2018
Grand River Aseptic Manufacturing announces equipment purchase to add vial filling capacity.
April 24, 2018
Porton will use biocatalyst technologies from Codexis to accelerate API development for clients.
April 20, 2018
The contract renewal allows AMRI to continue to provide medicinal chemistry and ADME services for advancing drug discovery programs in neurotherapeutics.
April 19, 2018
The company unveiled three new products to support single-use biomanufacturing and won an award for best technological innovation at INTERPHEX 2018.